Sponsor:
Viking Therapeutics, Inc.
Code:
NCT07868835
Conditions
Weight Loss
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
VK2735
Placebo comparator
Brief summary:
Conditions
Weight Loss
Study ID
NCT07868835
Start date
Nov, 2026
Status verified date
Nov, 2026
Completion date
Aug, 2028
Anticipated
Primary completion date
Jul, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
560 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
placebo comparator: Placebo Assignment
experimental: Active Assignment (Dose 1)
experimental: Active Assignment (Dose 2)
experimental: Active Assignment (Dose 3)
Interventions
VK2735
Placebo comparator
Primary outcome measure
Central contacts
Locations
Viking Clinical Site #1018
Recruiting
Chula Vista, California, United States, 91910
Contacts
Viking Clinical Site #1015
Recruiting
Lake Forest, California, United States, 92630
Contacts
Viking Clinical Site #1003
Recruiting
The Villages, Florida, United States, 32162
Contacts
Viking Clinical Site #1028
Recruiting
Springfield, Missouri, United States, 65807
Contacts
Viking Clinical Site #1035
Recruiting
Morehead City, North Carolina, United States, 28557
Contacts
Viking Clinical Site #1002
Recruiting
East Greenwich, Rhode Island, United States, 02818
Contacts
Sponsor
Viking Therapeutics, Inc.
Last update posted
Nov 16, 2026
Last verified
Nov, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-17. This information was provided to ClinicalTrials.gov by Viking Therapeutics, Inc. on 2026-11-16. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.